Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April–May, 2018: an epidemiological study

doi:10.1016/S0140-6736(18)31387-4

The Lancet

Volume 392, Issue 10143, 21–27 July 2018, Pages 213-221

https://doi.org/10.1016/S0140-6736(18)31387-4 Get rights and content

Summary

Background

On May 8, 2018, the Government of the Democratic Republic of the Congo reported an outbreak of Ebola virus disease in Équateur Province in the northwest of the country. The remoteness of most affected communities and the involvement of an urban centre connected to the capital city and neighbouring countries makes this outbreak the most complex and high risk ever experienced by the Democratic Republic of the Congo. We provide early epidemiological information arising from the ongoing investigation of this outbreak.

Methods

We classified cases as suspected, probable, or confirmed using national case definitions of the Democratic Republic of the Congo Ministère de la Santé Publique. We investigated all cases to obtain demographic characteristics, determine possible exposures, describe signs and symptoms, and identify contacts to be followed up for 21 days. We also estimated the reproduction number and projected number of cases for the 4-week period from May 25, to June 21, 2018.

Findings

As of May 30, 2018, 50 cases (37 confirmed, 13 probable) of Zaire ebolavirus were reported in the Democratic Republic of the Congo. 21 (42%) were reported in Bikoro, 25 (50%) in Iboko, and four (8%) in Wangata health zones. Wangata is part of Mbandaka, the urban capital of Équateur Province, which is connected to major national and international transport routes. By May 30, 2018, 25 deaths from Ebola virus disease had been reported, with a case fatality ratio of 56% (95% CI 39–72) after adjustment for censoring. This case fatality ratio is consistent with estimates for the 2014–16 west African Ebola virus disease epidemic (p=0·427). The median age of people with confirmed or probable infection was 40 years (range 8–80) and 30 (60%) were male. The most commonly reported signs and symptoms in people with confirmed or probable Ebola virus disease were fever (40 [95%] of 42 cases), intense general fatigue (37 [90%] of 41 cases), and loss of appetite (37 [90%] of 41 cases). Gastrointestinal symptoms were frequently reported, and 14 (33%) of 43 people reported haemorrhagic signs. Time from illness onset and hospitalisation to sample testing decreased over time. By May 30, 2018, 1458 contacts had been identified, of which 746 (51%) remained under active follow-up. The estimated reproduction number was 1·03 (95% credible interval 0·83–1·37) and the cumulative case incidence for the outbreak by June 21, 2018, is projected to be 78 confirmed cases (37–281), assuming heterogeneous transmissibility.

Interpretation

The ongoing Ebola virus outbreak in the Democratic Republic of the Congo has similar epidemiological features to previous Ebola virus disease outbreaks. Early detection, rapid patient isolation, contact tracing, and the ongoing vaccination programme should sufficiently control the outbreak. The forecast of the number of cases does not exceed the current capacity to respond if the epidemiological situation does not change. The information presented, although preliminary, has been essential in guiding the ongoing investigation and response to this outbreak.

Funding

None.

Introduction

On May 3, 2018, the Ministry of Health of the Democratic Republic of the Congo received a notification from the Health Division of Équateur Province of 21 cases of fever with haemorrhagic signs, including 17 community deaths, from the Ikoko Impenge Health Area, Bikoro Health Zone, which is approximately 125 km south of the provincial capital of Mbandaka. An investigation team, composed of members of the Ministry of Health, Médecins Sans Frontières, and WHO, travelled to Bikoro Health Zone from May 5 to May 6, 2018. Blood samples were collected from five hospitalised patients and transported to the National Institute of Biological Research in Kinshasa for laboratory testing on May 6, 2018. Of these five patients, two were identified as positive for Zaire ebolavirus by reverse transcription PCR. In line with the International Health Regulation requirements, the Ministry of Health notified WHO of the confirmed cases and declared the outbreak on May 8, 2018. Further investigation identified additional cases in neighbouring Wangata and Iboko health zones.

Research in context

Evidence before this study

This paper reviews preliminary epidemiological evidence emerging from the ongoing Ebola virus disease outbreak in the Democratic Republic of the Congo. Although much evidence exists from past outbreaks about the typical epidemiology and clinical characteristics of Ebola virus disease, each outbreak is unique, presenting different challenges and providing opportunities to strengthen scientific knowledge about this relatively rare and serious disease. We contrasted the results of our primary analyses against published evidence from past outbreaks occurring in similar contexts. We identified this evidence by searching PubMed with the terms “Ebola” AND “virus” AND “disease”; “Ebola” AND “Democratic Republic of the Congo”; and “West Africa” AND “Ebola”. We found 212 articles, reviewed 47 following review of abstracts for relevance, and selected 11 articles on the basis of applicability to context, retrospective analysis of outbreaks of Zaire Ebola virus disease, strength of information presented, and generalisability to the current outbreak. All selected studies were published after the end of the outbreak being studied. We obtained published epidemiological parameter estimates from a review published by Van Kerkhove and colleagues (2015), as well as estimates subsequently obtained from the west African Ebola virus disease epidemic.

Added value of this study

By publishing evidence as it emerges, we aim to ensure transparency and availability of information from this ongoing event in near real-time. To our knowledge, this is the most rapid scientific publication of preliminary data and analyses from an ongoing Ebola virus disease outbreak. While highlighting the ongoing efforts of the Ministry of Health of the Democratic Republic of the Congo and supporting partner agencies to investigate and control the current Ebola virus disease outbreak, we present emerging descriptive epidemiological characteristics of cases detected by the time of publication, and draw inferences about the case fatality ratio, the reproduction number, and case incidence projected from these data. Our results are informing response strategies.

Implications of all the available evidence

The nature and context of this Ebola virus disease outbreak present a formidable challenge to public health authorities. The presence of Ebola virus disease in three locations makes this response particularly challenging, and proximity to an urban centre with connections to Kinshasa and regional borders infers a substantially higher risk of national and regional spread than previous outbreaks of Ebola virus disease in the Democratic Republic of the Congo. Evidence emerging from this ongoing event suggests a similar epidemiological presentation to past outbreaks, with current capacity adequate to respond if recent trends continue. Our results, combined with past experiences, provide a strong evidence base to guide and further strengthen response measures, and, following this event, remain useful in informing the early evolution of Ebola virus disease outbreaks.

Ebola virus is a filovirus with five subspecies (Zaire, Bundibugyo, Sudan, Reston, and Taï Forest). It causes Ebola virus disease, which has a case fatality ratio of 25–90%.¹ The Zaire strain is the most fatal, with an overall case fatality ratio ranging from 69% to 88%.² Ebola virus disease is transmitted primarily through contact with the body fluids of symptomatic patients, most commonly in adults aged 17–44 years, with relative sparing of children younger than 16 years.3, 4, 5, 6 Transmission can be stopped by early diagnosis, patient isolation and care, infection control, safe and dignified burial of people who had died from Ebola virus disease, rigorous tracing of contacts, and, more recently, promising evidence on the use of targeted vaccination.3, 6, 7

The Democratic Republic of the Congo has had eight recorded Ebola virus disease outbreaks since 1976 (figure 1).4, 9 The last outbreak occurred in May, 2017, in Likati Health Zone in the Bas-Uélé Province, a remote area in the northeast of the country, causing a total of eight cases with four deaths. Most of the previous outbreaks have been confined to remote rural areas, with the exception of an outbreak in Kikwit, a town with a population of nearly 400 000 that resulted in 315 cases and 250 deaths.¹⁰ The ongoing response to the current outbreak in Èquateur Province includes use of traditional measures such as early identification, isolation and care of cases, contact tracing, safe and dignified burials, and culturally appropriate community mobilisation (including risk communication, community engagement, and social mobilisation). These traditional measures are being supplemented by use of the recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV) vaccine, with vaccination of first-line and second-line contacts. This is the first of several planned studies of the ongoing outbreak in the Democratic Republic of the Congo. We provide an early overview of the descriptive epidemiology, using the best data available from field teams working in response to the epidemic.

Section snippets

Case investigation and contact tracing

We used the Ebola virus disease case definitions of the Democratic Republic of the Congo Ministère de la Santé Publique (MSP) to classify cases as suspected, probable, or confirmed (panel).¹¹ Confirmation of cases required detection of Ebola virus RNA in blood or body fluids by reverse transcription PCR. We investigated all notified suspected, probable, and confirmed cases to record demographic characteristics, determine possible exposures, document information about illness onset and signs and

Results

As of May 30, 2018, 50 Ebola virus disease cases (37 confirmed, 13 probable) had been identified in Équateur Province, Democratic Republic of the Congo, with illness onset between April 5 and May 28, 2018 (figure 2). By May 30, 2018, there had been 25 deaths (unadjusted case fatality ratio 50%, 95% CI 36–64). After adjustment for censoring, the case fatality ratio was 56% (95% CI 39–72), ignoring uncertainty in the illness-onset-to-death distribution. On the basis of the recorded ages of cases

Discussion

Our analysis shows that the epidemiological features of the current outbreak in the Democratic Republic of the Congo, such as demographic characteristics and signs and symptoms of cases, are consistent with previous outbreaks of Ebola virus disease.16, 17, 18 Contact with other cases and participation in traditional burial rites for those who have died from Ebola virus disease are the most commonly reported exposures, similar to previous Ebola virus disease outbreaks,¹⁵ reinforcing the

References (27)

AM Henao-Restrepo et al.
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
Lancet
(2017)
L Hunt et al.
Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study
Lancet Infect Dis
(2015)
P Shears et al.
Ebola virus disease in Africa: epidemiology and nosocomial transmission
J Hosp Inf
(2015)
AC Dunn et al.
Nosocomial transmission of Ebola virus disease on pediatric and maternity wards: Bombali and Tonkolili, Sierra Leone, 2014
Am J Inf Control
(2016)
Ebola Virus Disease Factsheet
M Van Kerkhove et al.
A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making
Sci Data
(2015)
Ebola haemorrhagic fever in Zaire, 1976. Report of an International Commission
Bull World Health Organ
(1978)
Ebola virus disease—the Democratic Republic of the Congo
West African Ebola epidemic after one year—slowing but not yet under control
N Engl J Med
(2015)
Ebola virus disease in west Africa—the first 9 months of the epidemic and forward projections
N Engl J Med
(2014)

Ebola virus disease. History of Ebola in Democratic Republic of the Congo

Years of Ebola virus disease outbreaks

AS Khan et al.

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995

J Infect Dis

(1999)

Cited by (85)

The basic reproduction number (R<inf>0</inf>) of ebola virus disease: A systematic review and meta-analysis
2024, Travel Medicine and Infectious Disease
Ebola virus disease (Ebola) is highly pathogenic, transmissible, and often deadly, with debilitating consequences. Superspreading within a cluster is also possible. In this study, we aim to document Ebola basic reproduction number (R₀): the average number of new cases associated with an Ebola case in a completely susceptible population.
We undertook a systematic review and meta-analysis. We searched PubMed, EMBASE, and Web of Science for studies published between 1976 and February 27, 2023. We also manually searched the reference lists of the reviewed studies to identify additional studies. We included studies that reported R₀ during Ebola outbreaks in Africa. We excluded studies that reported only the effective reproduction number (R_t). Abstracting data from included studies was performed using a pilot-tested standard form. Two investigators reviewed the studies, extracted the data, and assessed quality. The pooled R₀ was determined by a random-effects meta-analysis. R₀ was stratified by country. We also estimated the theoretically required immunization coverage to reach herd-immunity using the formula of (1-1/R₀) × 100 %.
The search yielded 2042 studies. We included 53 studies from six African countries in the systematic review providing 97 Ebola mean R₀ estimates. 27 (with 46 data points) studies were included in the meta-analysis. The overall pooled mean Ebola R₀ was 1.95 (95 % CI 1.74–2.15), with high heterogeneity (I² = 99.99 %; τ² = 0.38; and p < 0.001) and evidence of small-study effects (Egger's statistics: Z = 4.67; p < 0.001). Mean Ebola R₀ values ranged from 1.2 to 10.0 in Nigeria, 1.1 to 7 in Guinea, 1.14 to 8.33 in Sierra Leone, 1.13 to 5 in Liberia, 1.2 to 5.2 in DR Congo, 1.34 to 2.7 in Uganda, and from 1.40 to 2.55 for all West African countries combined. Pooled mean Ebola R₀ was 9.38 (95 % CI 4.16–14.59) in Nigeria, 3.31 (95 % CI 2.30–4.32) in DR Congo, 2.0 (95 % CI 1.25–2.76) in Uganda, 1.83 (95 % CI 1.61–2.05) in Liberia, 1.73 (95 % CI 1.47–2.0) in Sierra Leonne, and 1.44 (95 % CI 1.29–1.60) in Guinea. In theory, 50 % of the population needs to be vaccinated to achieve herd immunity, assuming that Ebola vaccine would be 100 % effective.
Ebola R₀ varies widely across countries. Ebola has a much wider R₀ range than is often claimed (1.3–2.0). It is possible for an Ebola index case to infect more than two susceptible individuals.
Data flows during public health emergencies in LMICs: A people-centered mapping of data flows during the 2018 ebola epidemic in Equateur, DRC
2023, Social Science and Medicine
Citation Excerpt :
Overall, the 2018 Équateur response did not leverage pre-existing epidemic response capacity to its best effect. The lack of integration between routine and health emergency response systems caused inconsistencies in case identification and community-based surveillance, lack of experience with electronic reporting tools, lack of interoperability between contact tracing and case databases (Barry et al., 2018), and delays in communications with central coordination (Kalambay Ntembwa and Van Lerberghe, 2015). Routine data collection generated by local healthcare facilities was central to the response but was not easily inter-operable with parallel (and sometimes competing) information systems established for specific response purposes.
In infectious outbreaks, rapid case detection and reporting, coordination, and context-specific strategies are needed for rapid containment. Data sharing between actors, and the speed and content of data flows, is essential for expediting epidemic response. In this study, researchers mapped data flows during the 2018 Ebola Virus Disease (EVD) outbreak in Equateur Province in the Democratic Republic of the Congo using semi-structured interviews, ethnographic research, and focus groups with EVD response actors. During this research, we mapped and tracked data collection, transmission, storage, sharing, and use patterns. Target participants included: key organizational actors in the EVD outbreaks responses, including local (primary health, community-based, hospital), provincial (MoPH, DRC Red Cross), and international (WHO, UN organizations, international first-responders) stakeholders. We found that a community-based surveillance system enabled the rapid detection of a hemorrhagic fever outbreak, resulting in the rapid laboratory confirmation of EVD. With the arrival of international organizations to provide support to the EVD response, routine surveillance systems continued to function robustly. However, the establishment of a vertical EVD response architecture created challenges for the response. Data flows during the Equateur outbreak were hampered by numerous challenges in the domains of early warning, line lists of cases, and contact tracing, which impeded surveillance and data flows. We therefore argue that structuring health information systems for preparedness requires taking a person-centered approach to data production, flow, and analysis.
Measuring progress of public health response and preparedness
2023, Modernizing Global Health Security to Prevent, Detect, and Respond
Public health preparedness is a country's first line of defense to prevent, detect, and respond to protect its people from catastrophic events and mass casualties. Unfortunately, many countries are not well equipped to protect their citizens from these events, as illustrated by the current COVID-19 pandemic. This chapter examines eight preparedness tools currently implemented by health agencies across the global, outlining each one's strengths and weaknesses, and concluding with proposed visions for the future and actionable steps health agencies and governments can refer as they refine their tools in preparation for the next outbreak.
Modeling a sustainable vaccine supply chain for a healthcare system
2022, Journal of Cleaner Production
This study develops a vaccine supply chain (VSC) to ensure sustainable distribution during a global crisis in a developing economy. In this study, a multi-objective mixed-integer programming (MIP) model is formulated to develop the VSC, ensuring the entire network's economic performance. This is achieved by minimizing the overall cost of vaccine distribution and ensuring environmental and social sustainability by minimizing greenhouse gas (GHG) emissions and maximizing job opportunities in the entire network. The shelf-life of vaccines and the uncertainty associated with demand and supply chain (SC) parameters are also considered in this study to ensure the robustness of the model. To solve the model, two recently developed metaheuristics—namely, the multi-objective social engineering optimizer (MOSEO) and multi-objective feasibility enhanced particle swarm optimization (MOFEPSO) methods—are used, and their results are compared. Further, the Technique for Order Preference by Similarity to Ideal Solution (TOPSIS) model has been integrated into the optimization model to determine the best solution from a set of non-dominated solutions (NDSs) that prioritize environmental sustainability. The results are analyzed in the context of the Bangladeshi coronavirus disease (COVID-19) vaccine distribution systems. Numerical illustrations reveal that the MOSEO-TOPSIS model performs substantially better in designing the network than the MOFEPSO-TOPSIS model. Furthermore, the solution from MOSEO results in achieving better environmental sustainability than MOFEPSO with the same resources. Results also reflect that the proposed MOSEO-TOPSIS can help policymakers establish a VSC during a global crisis with enhanced economic, environmental, and social sustainability within the healthcare system.
Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein
2021, Immunity
The 2014 Ebola virus disease (EVD) outbreak in West Africa and the subsequent outbreaks of 2018–2020 in Equator and North Kivu provinces of the Democratic Republic of the Congo illustrate the public health challenges of emerging and reemerging viruses. EVD has a high case fatality rate with a rapidly progressing syndrome of fever, rash, vomiting, diarrhea, and bleeding diathesis. Recently, two monoclonal-antibody-based therapies received United States Food and Drug Administration (FDA) approval, and there are several other passive immunotherapies that hold promise as therapeutics against other species of Ebolavirus. Here, we review concepts needed to understand mechanisms of action, present an expanded schema to define additional sites of vulnerability on the viral glycoprotein, and review current antibody-based therapeutics. The concepts described are used to gain insights into the key characteristics that represent functional targets for immunotherapies against Zaire Ebolavirus and other emerging viruses within the Ebolavirus genus.
Ebola virus outbreak preparedness plan for developing Nations: Lessons learnt from affected countries
2021, Journal of Infection and Public Health
Ebola virus (EBOV); a public health emergency of international concern,is known to pose threat of global outbreaks. EBOV has spread in African continent and due to unchecked international travel, importation of cases has been reported in different countries. In this alarming scenario, developing countries need to evaluate and upgrade their preparedness plan to contain the spread of EBOV. The present review lays down the updated preparedness plan for developing countries to contain future EBOV outbreaks.
The literature on EBOV outbreaks and preparedness strategies reported were searched on Pubmed and Google Scholar using the MeSH terms such as "Ebola virus disease, Epidemic, Outbreak, Imported case, Preparedness, Public health interventions" combined with Boolean operator (OR) for the period of 2011–2020. Additionally, World Health organization (WHO) and Centers for Disease Control & Prevention (CDC) websites were searched for the guidelines, reports, containment strategies, containment plan of countries, actions taken by countries and international partners, etc.
The present review analyzed the EBOV outbreaks between 2011–2020 and containment strategies used by the affected countries. Based on the lessons learned from EBOV outbreaks and personal experience in infectious disease management, we have recommended a preparedness and response plan for EBOV containment in developing countries.
Developing countries are particularly vulnerable to major outbreaks of EBOV due to increased international travel and unchecked transmission. The recommended preparedness plan will help developing counties to contain EBOV outbreaks in future.

View all citing articles on Scopus

^†: Collaborators listed at end of the Article

View full text

ArticlesOutbreak of Ebola virus disease in the Democratic Republic of the Congo, April–May, 2018: an epidemiological study

Summary

Background

Methods

Findings

Interpretation

Funding

Introduction

Section snippets

Case investigation and contact tracing

Results

Discussion

Lancet

Lancet Infect Dis

J Hosp Inf

Am J Inf Control

Ebola Virus Disease Factsheet

A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making

Sci Data

Ebola haemorrhagic fever in Zaire, 1976. Report of an International Commission

Bull World Health Organ

Ebola virus disease—the Democratic Republic of the Congo

West African Ebola epidemic after one year—slowing but not yet under control

N Engl J Med

Ebola virus disease in west Africa—the first 9 months of the epidemic and forward projections

N Engl J Med

Ebola virus disease. History of Ebola in Democratic Republic of the Congo

Years of Ebola virus disease outbreaks

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995

J Infect Dis

Articles
Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April–May, 2018: an epidemiological study